(Q44062554)

29 November 2017

Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study (English)

1 reference

29 November 2017

1 reference

1 reference

1

Eero Pukkala

1 reference

29 November 2017

3

Risto Sankila

1 reference

29 November 2017

4

Kaija Holli

1 reference

29 November 2017

Pentti Kyyrönen

2

1 reference

PubMed ID

12115550

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

International Journal of Cancer

29 November 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

100

1 reference

29 November 2017

337-341

1 reference

29 November 2017

3

1 reference

On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study

29 November 2017

1 reference

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

21 January 2018

1 reference

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

21 January 2018

1 reference

The pharmacology and clinical uses of tamoxifen

21 January 2018

1 reference

A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats

21 January 2018

1 reference

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

21 January 2018

1 reference

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens

21 January 2018

1 reference

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

21 January 2018

1 reference

Tamoxifen therapy for breast cancer and endometrial cancer risk.

21 January 2018

1 reference

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

21 January 2018

1 reference

Risk of endometrial cancer after tamoxifen treatment of breast cancer

21 January 2018

1 reference

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 January 2018

1 reference

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

21 January 2018

1 reference

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

21 January 2018

1 reference

A new triphenylethylene compound, Fc-1157a. I. Hormonal effects

21 January 2018

1 reference

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

21 January 2018

1 reference

Second cancers after adjuvant tamoxifen therapy for breast cancer

21 January 2018

1 reference

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10454

1 reference

release_nvqckdrdpfdfrcpbzldqziwoj4

29 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nvqckdrdpfdfrcpbzldqziwoj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12115550

1 reference

PubMed ID

12115550